0
United States sales and distribution of medically important antimicrobial drugs approved for use in food-producing animals decreased by 3% between 2019 and 2020. That is a 38% decrease since 2015, which was the peak year of sales. This suggests that continued efforts to support the judicious use of antimicrobials in food-producing animals are having an impact.
While sales data on antimicrobial drug products intended for food-producing animals do not necessarily reflect the actual use of antimicrobial drugs, sales volume observed over time can be a valuable indicator of market trends related to these products. FDA recognizes that fluctuations in sales volume may occur over time in response to various factors, including changing animal health needs or changes in animal populations. Given the substantial change that occurred with transitioning a large number of products containing medically important antimicrobials from over-the-counter use to a marketing status requiring veterinary oversight at the beginning of 2017, some rebound in the reported sales volume in subsequent years was not unexpected as affected stakeholders adjusted to the new requirements.
The domestic sales and distribution of medically important antimicrobials approved for use in food-producing animals for 2020 included:
- An estimated 41% was intended for use in cattle,
- an estimated 41% intended for use in swine (2,451,382 kg of active ingredient),
- an estimated 12% intended for use in turkeys,
- an estimated 2% intended for use in chickens,
- and an estimated 4% intended for use in other species/unknown.
December 14, 2021/ FDA/ United States.
https://www.fda.gov/
